Beth C Seidenberg's Net Worth
Estimate Recalculated Nov 7, 2024 05:00PM EST
Who is Beth C Seidenberg
Beth C Seidenberg has an estimated net worth of $10.2 Million. This is based on reported shares across multiple companies, which include Sagimet Biosciences Inc., ACELYRIN, Inc., Vera Therapeutics, Inc., Atara Biotherapeutics, Inc., Progyny, Inc., BIOCRYST PHARMACEUTICALS INC, ARMO BioSciences, Inc., TESARO, Inc., Epizyme, Inc., AMGEN INC, and Kyverna Therapeutics, Inc..
SEC CIK
Beth C Seidenberg's CIK is 0001184592
Past Insider Trading and Trends
2021 was Beth C Seidenberg's most active year for acquiring shares with 13 total transactions. Beth C Seidenberg's most active month to acquire stocks was the month of May. 2019 was Beth C Seidenberg's most active year for disposing of shares, totalling 8 transactions. Beth C Seidenberg's most active month to dispose stocks was the month of December. 2023 saw Beth C Seidenberg paying a total of $1,144,991.73 for 415,996 shares, this is the most they've acquired in one year. In 2019 Beth C Seidenberg cashed out on 111,168 shares for a total of $3,443,025.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
